Liver disease, traditionally linked to alcohol consumption, is increasingly diagnosed in non-drinkers, particularly through a condition known as metabolic dysfunction-associated steatotic liver disease (MASLD). According to Dr. Naveen Ganjoo, Senior Consultant in Hepatology at Aster RV Hospital in Bengaluru, MASLD arises when excess fat accumulates in the liver due to factors such as poor diet, lack of exercise, obesity, diabetes, and high cholesterol. The disease often develops silently, with individuals showing no symptoms until routine health checks reveal abnormal liver enzyme levels or fatty liver changes. Notably, MASLD can affect individuals of normal weight, emphasizing that metabolic health is crucial. If untreated, MASLD can progress to severe liver damage, cirrhosis, or liver cancer. The rising prevalence of this condition poses a significant public health challenge, especially in India, where lifestyle changes have led to increased obesity and diabetes rates. Fortunately, early-stage MASLD can often be reversed through lifestyle modifications, including a balanced diet, regular physical activity, and weight management. Awareness and early detection are essential for combating this silent yet growing health issue.